This assay is designed for the detection of anti-CCP3 IgG and IgA antibodies in patient sera, citrated or EDTA plasma. The presence of these antibodies can aid in the diagnosis of rheumatoid arthritis (RA), including RA diagnosed within 2 years of presentation of symptoms.

IVD-In Vitro Diagnostic Use / CE marked

Technology
ELISA

CLIA complexity
High

Package Size
10 X 96 wells

Disease Area Application
Rheumatoid Arthritis (RA)

Antigen Source
Synthetic peptide

Contact us

EMAIL:

customerservice.na@werfen.com

PHONE:

1-800-955-9525